The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Open accessAbstract
Once osteoblasts have completed their bone-forming function, they are either entrapped in bone matrix and become osteocytes or remain on the surface as lining cells. Nonetheless, 50–70% of the osteoblasts initially present at the remodeling site cannot be accounted for after enumeration of lining cells and osteocytes. We hypothesized that the missing osteoblasts die by apoptosis and that growth factors and cytokines produced in the bone microenvironment influence this process. We report that murine osteoblastic MC3T3-E1 cells underwent apoptosis following removal of serum, or addition of tumor necrosis factor (TNF), as indicated by terminal deoxynucleotidyl transferase–mediated dUTP-nick end labeling and DNA fragmentation studies. Transforming growth factor-β and interleukin-6 (IL-6)–type cytokines had antiapoptotic effects because they were able to counteract the effect of serum starvation or TNF. In addition, anti-Fas antibody stimulated apoptosis of human osteoblastic MG-63 cells and IL-6–type cytokines prevented these changes. The induction of apoptosis in MG-63 cells was associated with an increase in the ratio of the proapoptotic protein bax to the antiapoptotic protein bcl-2, and oncostatin M prevented this change. Examination of undecalcified sections of murine cancellous bone revealed the presence of apoptotic cells, identified as osteoblasts by their proximity to osteoid seams and their juxtaposition to cuboidal osteoblasts. Assuming an osteoblast life span of 300 h and a prevalence of apoptosis of 0.6%, we calculated that the fraction that undergo this process in vivo can indeed account for the missing osteoblasts. These findings establish that osteoblasts undergo apoptosis and strongly suggest that the process can be modulated by growth factors and cytokines produced in the bone microenvironment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At this stage, the mature osteoblasts can undergo apoptosis or become osteocytes or bone lining cells [47, 48].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [48]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationSuppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,469
(2019) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,690
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Self-citationCompston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,383
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D., Mundy, G. R., & Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,039
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001
Self-citation
Research works printed but not linked: 3
- Arnott, 1995, Evidence for a role of programmed cell death in the regulation of bone formation in adult human bone, J Bone Miner Res, 10, S216
- Parfitt, 1990, Bone, Vol 1: The Osteoblast and Osteocyte, 351
- Bellido, 1997, gp130/STAT3 activation stimulates the transcription of the cyclin dependent kinase inhibitor p21WAF1,CIP1 gene in osteoblasts: A prerequisite for the biologic effects of IL-6 type cytokines, J Bone Miner Res, 12, S159
Cited by
Sorted by citations
Items 101–200 of 577
Adynamic bone in patients with chronic kidney disease
Andress, D. L. (2008) · Kidney International · doi:10.1038/ki.2008.60 · Cited by 129
Osteoblast responses to nucleotides increase during differentiation
Orriss, I. R., Knight, G. E., Ranasinghe, S., Burnstock, G., & Arnett, T. R. (2006) · Bone · doi:10.1016/j.bone.2006.02.063 · Cited by 127
“Despite the clear link between the P2X7 receptor and cell death [33], the low prevalence of apoptosis in osteoblasts [34] suggests that this is unlikely to be a major function for P2X7 receptors in bone cell metabolism.”
BackgroundZhou, Y., Deng, Y., Liu, Z., Yin, M., Hou, M., Zhao, Z., Zhou, X., & Yin, L. (2021) · Science Advances · doi:10.1126/sciadv.abl6432 · Cited by 128
“Elevated TNF- level will induce apoptosis of osteoblasts (22, 23).”
BackgroundGilbert, L. C., Rubin, J. E., & Nanes, M. S. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00534.2004 · Cited by 124
“TNF has been shown to cause apoptosis of mature OB in culture; however, this effect of TNF is dependent on cell type and culture conditions (5, 16, 19, 21, 34).”
BackgroundZhang, Q., Riddle, R. C., Yang, Q., Rosen, C. J., Guttridge, D. C., Dirckx, N., Monier‐Faugere, M., Farber, C. R., & Clemens, T. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905489116 · Cited by 123
Magnusson, P., Larsson, L., Magnusson, M., Davie, M. W. J., & Sharp, C. A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.11.1926 · Cited by 121
“osteoblasts are entrapped in bone matrix becoming osteocytes, or remain on the surface as bone lining cells, or undergo apoptosis.((45))”
BackgroundPathological role of osteoclast costimulation in arthritis-induced bone loss
Ochi, S., Shinohara, M., Sato, K., Gober, H.-J., Koga, T., Kodama, T., Takai, T., Miyasaka, N., & Takayanagi, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701971104 · Cited by 123
Almeida, M., Martín-Millán, M., Ambrogini, E., Bradsher, R., Han, L., Chen, X.-D., Roberson, P., Weinstein, R., O'Brien, C. A., Jilka, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091017 · Cited by 126
“Osteoblastic cells derived from mouse calvaria or bone marrow were obtained and cultured as described previously,((33)) and during exposure to E2, the cultures were maintained in 2% charcoal-stripped serum.”
MethodSelf-citationMechanisms of bone anabolism regulated by statins
Ruan, F., Zheng, Q., & Wang, J. (2012) · Bioscience Reports · doi:10.1042/bsr20110118 · Cited by 117
The role of whole blood in thrombin generation in contact with various titanium surfaces
Thor, A. L. I., Rasmusson, L., Wennerberg, A., Thomsen, P., Hirsch, J., Nilsson, B., & Hong, J. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.020 · Cited by 117
“[34] have reported antiapoptotic effect of TGF-b on osteblastic cells.”
BackgroundOsteoimmunology: cytokines and the skeletal system
Lee, S., Kim, T. S., Choi, Y., & Lorenzo, J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.7.495 · Cited by 117
“Additionally, TNF-α is potently pro-apoptotic for osteoblasts (36), possibly through Fas-Fas ligand (FasL) signaling (37).”
BackgroundXiong, J., Almeida, M., & O’Brien, C. A. (2018) · Bone · doi:10.1016/j.bone.2018.04.001 · Cited by 115
“Calvaria cells were isolated from 5-day-old YAPf/f,TAZf/f mice as described previously [32] and were transduced with adenovirus encoding Cre recombinase (Ad-Cre) or GFP (Ad-GFP) (Vector Biolabs, Malvern, PA) at an MOI of 30 for 6 hours and allowed to recover for 72 hours.”
MethodPineault, K. M., Song, J. Y., Kozloff, K. M., Lucas, D., & Wellik, D. M. (2019) · Nature Communications · doi:10.1038/s41467-019-11100-4 · Cited by 113
Fate of growth plate hypertrophic chondrocytes: Death or lineage extension?
Tsang, K. Y., Chan, D. T.-M., & Cheah, K. S. E. (2015) · Development Growth & Differentiation · doi:10.1111/dgd.12203 · Cited by 110
“The mature osteoblasts might undergo apoptosis (Jilka et al. 1998, 1999), or become embedded into the bone matrix and become osteocytes.”
BackgroundHomocysteine enhances apoptosis in human bone marrow stromal cells
Kim, D. J., Koh, J., Lee, O., Kim, N. J., Lee, Y., Kim, Y. S., Park, J., Lee, K., & Kim, G. S. (2006) · Bone · doi:10.1016/j.bone.2006.03.004 · Cited by 111
“The majority of osteoblasts are fated to undergo apoptosis and the rate of apoptosis is responsible for the regulation of bone formation [26].”
BackgroundSfeir, J. G., Drake, M. T., Khosla, S., & Farr, J. N. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.03.011 · Cited by 112
Behaviour of Nitinol in osteoblast-like ROS-17 cell cultures
Kapanen, A. I., Ilvesaro, J. M., Danilov, A., Ryhänen, J., Lehenkari, P. P., & Tuukkanen, J. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00143-0 · Cited by 108
Heterogeneity of murine periosteum progenitors involved in fracture healing
Matthews, B. G., Novak, S., Sbrana, F. V., Funnell, J. L., Cao, Y., Buckels, E. J., Grčević, D., & Kalajzić, I. (2021) · eLife · doi:10.7554/elife.58534 · Cited by 108
Chandra, A., Lan, S., Zhu, J., Siclari, V. A., & Qin, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447250 · Cited by 107
“TNF is a proinflammatory cytokine secreted by a variety of cell types in bone, and it functions as an inducer of apoptosis for osteoblasts (26).”
BackgroundSilvestris, F., Cafforio, P., Calvani, N., & Dammacco, F. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05084.x · Cited by 105
“These cytokines, however, have also been demonstrated to act as strong apoptosis-inducers in murine (Kitajima et al, 1996) as well as in human osteoblasts (Jilka et al, 1998).”
BackgroundVertino, A. M., Bula, C. M., Chen, J., Almeida, M., Han, L., Bellido, T., Kousteni, S., Norman, A. W., & Manolagas, S. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410720200 · Cited by 105
Self-citationStreet, J., & Lenehan, B. J. (2009) · Journal of Orthopaedic Surgery and Research · doi:10.1186/1749-799x-4-19 · Cited by 102
“Disuse osteopenia, periprosthetic and infection related bone loss are all associated with increases in 'pathological' osteoblast apoptosis, enhanced cell suicide mediated by proinflammatory cytokines such as TNF alpha, anti CD 95-IgM, Il-1β and Il-6 [2,17-20,22].”
BackgroundCollagen and non-collagenous proteins molecular crosstalk in the pathophysiology of osteoporosis
Licini, C., Vitale‐Brovarone, C., & Mattioli‐Belmonte, M. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.09.001 · Cited by 116
Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts
Baum, R., & Gravallese, E. M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8515-6 · Cited by 103
“In addition, high dose TNF treatment of osteoblast precursor cells induces their apoptosis [120].”
Scaffidi, A. K., Mutsaers, S. E., Moodley, Y. P., McAnulty, R. J., Laurent, G. J., Thompson, P. J., & Knight, D. A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704769 · Cited by 104
“OSM has also been shown to inhibit osteoblast apoptosis by preventing an increase in the expression of the pro-apoptotic protein Bax (Jilka et al., 1998).”
BackgroundAhuja, S. S., Zhao, S., Bellido, T., Plotkin, L. I., Jiménez, F., & Bonewald, L. F. (2003) · Endocrinology · doi:10.1210/en.2002-221136 · Cited by 101
Self-citationIntracellular Staphylococcus aureus induces apoptosis in mouse osteoblasts
Tucker, K. A., Reilly, S. S., Leslie, C. S., & Hudson, M. C. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09096.x · Cited by 99
“Osteoblasts have been demonstrated to undergo apoptosis in vivo, and results suggest that the process can be modulated by growth factors and cytokines produced in the bone microenvironment [17].”
BackgroundKim, H., Ponte, F., Nookaew, I., Ucer, S., Carvalho, A. L., Iyer, S. V., Warren, A. D., Aykin‐Burns, N., Krager, K. J., Sardão, V. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68890-7 · Cited by 101
Self-citationExpression and function of TNF-family proteins and receptors in human osteoblasts>
Bu, R., Borysenko, C. W., Li, Y., Cao, L., Sabokbar, A., & Blair, H. C. (2003) · Bone · doi:10.1016/j.bone.2003.07.006 · Cited by 96
“The literature is complex and it is not possible to review all of the hypotheses, but resistance to apoptosis may be related to expression of anti-apoptotic proteins including FLIP [30], and to survival signals including TGF- [14,40], vitamin D [41], and IL-6 [14].”
BackgroundResultInfluentialMediators of inflammation and bone remodeling in rheumatic disease
Shaw, A. T., & Gravallese, E. M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.013 · Cited by 95
“TNF inhibits osteoblast differentiation and bone formation [45] by decreasing Runx2 [46] and osteocalcin expression [47], as well as inducing apoptosis of osteoblasts [48].”
BackgroundPavalko, F. M., Gerard-O’Riley, R. L., Ponik, S. M., Gallagher, P. J., Jin, Y., & Norvell, S. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10221 · Cited by 95
“A variety of agents have been used to induce apoptosis of osteoblasts in vitro including TNF-a (Kitajima et al., 1996; Hill et al., 1997; Jilka et al., 1998; Chae et al., 2000).”
BackgroundOncostatin M: Signal transduction and biological activity
Gómez-Lechón, M. J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00296-9 · Cited by 95
Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Nara, Y., Pramusita, A., Kinjo, R., Ma, J., Kanou, K., & Mizoguchi, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031481 · Cited by 106
Tanaka, Y., Maruo, A., Fujii, K., Nomi, M., Nakamura, T., Eto, S., & Minami, Y. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.1912 · Cited by 94
“(40,41) Interestingly, Jilka et al.(42) recently showed that TGF-b prevents osteoblast apoptosis.”
BackgroundPavlin, D., Dove, S., Zadro, R., & Gluhak‐Heinrich, J. (2000) · Calcified Tissue International · doi:10.1007/s00223001105 · Cited by 90
Osteoblast Recruitment Routes in Human Cancellous Bone Remodeling
Kristensen, H. B., Andersen, T. L., Marcussen, N., Rolighed, L., & Delaissé, J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.022 · Cited by 88
Genever, P. G., & Skerry, T. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0594fje · Cited by 87
“As bone formation progresses and approaches completion, some osteoblasts differentiate into osteocytes and are enveloped by the developing matrix, others become quiescent bone-lining cells, whereas the remainder are believed to undergo apoptosis (1, 2).”
BackgroundBreast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation
Mastro, A. M., Gay, C. V., Welch, D. R., Donahue, H. J., Jewell, J., Mercer, R. R., DiGirolamo, D. J., Chislock, E. M., & Guttridge, K. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10746 · Cited by 83
“Nevertheless apoptotic osteoblasts can be detected under conditions of excessive loss [Jilka et al., 1998; Weinstein et al., 1998] or rapid turnover [Cerri et al.”
BackgroundApoptosis and Survival of Osteoblast-like Cells Are Regulated by Surface Attachment
Grigoriou, V., Shapiro, I. M., Cavalcanti‐Adam, E. A., Composto, R. J., Ducheyne, P., & Adams, C. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402550200 · Cited by 86
Karsdal, M. A., Andersen, T., Bonewald, L. F., & Christiansen, C. (2004) · DNA and Cell Biology · doi:10.1089/104454904322964751 · Cited by 85
“Thus, it is hypothesized that many osteoblasts undergo apoptosis after completion of bone matrix synthesis (Jilka et al ., 1998) and a small shift in this delicate balance, for example, by pharmaceutical intervention, could lead to more viable osteocytes, resulting in increased bone mass and…”
Hormonal regulation of physiological cell turnover and apoptosis
Medh, R. D., & Thompson, E. B. (2000) · Cell and Tissue Research · doi:10.1007/s004419900159 · Cited by 85
“Although estrogen deficiency increases the differentiation of bone marrow progenitor cells into osteoclasts and osteoblasts, osteoclastogenesis predominates (Jilka et al. 1998a; Riggs et al. 1998).”
BackgroundDaponte, V., Henke, K., & Drissi, H. (2024) · eLife · doi:10.7554/elife.95083 · Cited by 89
“Mature osteoblasts can either undergo apoptosis ( Jilka et al., 1998 ), become embedded in the matrix as osteocytes ( Compton and Lee, 2014 ), or transition into bone lining cells ( Miller and Jee, 1987 ).”
BackgroundDebiais, F., Lefevre, G. M., Lemonnier, J., Mée, S. L., Lasmoles, F., Mascarelli, F., & Marie, P. J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.032 · Cited by 80
Jilka, R. L., O’Brien, C. A., Bartell, S. M., Weinstein, R. S., & Manolagas, S. C. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.145 · Cited by 82
“In support of this notion, TGF-b, an established inhibitor of osteoblast apoptosis,((50)) is released from the bone matrix in vivo and in vitro.”
BackgroundMethodInfluentialSelf-citationPTHrP Signaling Targets Cyclin D1 and Induces Osteoblastic Cell Growth Arrest
Datta, N. S., Chen, C., Berry, J. E., & McCauley, L. K. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050106 · Cited by 77
“Human PTHrP(1-34) was from Bachem (Torrance, CA, USA).”
MethodIncreased Osteoblast Apoptosis in Apert Craniosynostosis
Lemonnier, J., Haÿ, E., Delannoy, P., Fromigué, O., Lomri, A., Modrowski, D., & Marie, P. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64139-9 · Cited by 77
“12,31,32 The molecular mechanisms that are downstream of FGF/FGFR interactions and that cause apoptosis in osteoblasts remain primarily unknown.”
BackgroundToo much death can kill you: inhibiting intrinsic apoptosis to treat disease
Li, K., van Delft, M. F., & Dewson, G. (2021) · The EMBO Journal · doi:10.15252/embj.2020107341 · Cited by 78
“The induction of human osteoblast apoptosis was associated with an increased ratio of pro-apoptotic proteins to anti-apoptotic proteins (Jilka et al, 1998).”
The skeleton as a unique environment for breast cancer cells
Mastro, A. M., Gay, C. V., & Welch, D. R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022995403081 · Cited by 76
“Other molecules such as IL-6 and IGF [64, 76] have been identified as anti-apoptotic because their”
BackgroundInhibition of osteoblast apoptosis by thrombin
Pagel, C. N., de Niese, M. R., Abraham, L. A., Chinni, C., Song, S., Pike, R. N., & Mackie, E. J. (2003) · Bone · doi:10.1016/s8756-3282(03)00209-6 · Cited by 75
“A number of endogenous growth factors and hormones have already been shown to be capable of inhibiting osteoblast apoptosis, including TGF , IL-6, IGF-II, and FGF-2 [29,40–42].”
Backgroundα-Lipoic Acid Inhibits TNF-α-Induced Apoptosis in Human Bone Marrow Stromal Cells
Byun, C.-H., Koh, J., Kim, D. K., Park, S.-I., Lee, K., & Kim, G. S. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050302 · Cited by 73
Wikman, H., Risch, A., Klimek, F., Schmezer, P., Spiegelhalder, B., Dienemann, H., Kayser, K., Schulz, V., Drings, P., & Bartsch, H. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001215)88:6 · Cited by 162
IL-6 receptor expression and IL-6 effects change during osteoblast differentiation
Li, Y., Bäckesjö, C., Haldosén, L.-A., & Lindgren, U. (2008) · Cytokine · doi:10.1016/j.cyto.2008.05.007 · Cited by 75
Modulation of Osteoblastic Cell Efferocytosis by Bone Marrow Macrophages
Michalski, M. N., Koh, A. J., Weidner, S., Roca, H., & McCauley, L. K. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25567 · Cited by 72
“Of the osteoblasts initially at remodeling sites, 30–50% become osteocytes and bone-lining cells, which leaves a large percentage of cells thought to undergo apoptosis [Jilka et al., 1998].”
BackgroundUpregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease
Silvestris, F., Cafforio, P., Tucci, M., Grinello, D., & Dammacco, F. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04374.x · Cited by 72
“However, they are highly susceptible to apoptosis by either TNFa (Kitajima et al, 1996; Jilka et al, 1998) or Fas/Fas-L (Kawakami et al, 1997) pathways, as most of them initially present at the remodelling sites usually die in response to the increased secretion of growth factors and cytokines…”
BackgroundYousfi, M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.359 · Cited by 71
Bone structure and metabolism in a rodent model of male senile osteoporosis
Pietschmann, P., Skalicky, M., Kneissel, M., Rauner, M., Hofbauer, G. F. L., Stupphann, D., & Viidik, A. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.08.008 · Cited by 70
p38 MAPK Regulates IL‐1β Induced IL‐6 Expression Through mRNA Stability in Osteoblasts
Patil, C. S., Zhu, X., Rossa, C., Kim, Y., & Kirkwood, K. L. (2004) · Immunological Investigations · doi:10.1081/imm-120034231 · Cited by 69
“Because of the interdependent nature of the production of IL-1, IL-6, and TNF, a significant increase in one of them may amplify, in a cascade fashion, the effect of the others (Jilka et al., 1998).”
Nonsteroidal Anti-Inflammatory Drug Effects on Osteoblastic Cell Cycle, Cytotoxicity, and Cell Death
Chang, J., Wang, G., Tsai, S.-T., & Ho, M. (2005) · Connective Tissue Research · doi:10.1080/03008200500344025 · Cited by 69
“Several growth factors and cytokines produced in the bone microenvironment were shown to modulate the osteoblastic apoptosis during osteoblast development [11].”
BackgroundMelatonin restores the mitochondrial production of ATP in septic mice.
López, L. C., Escames, G., Ortiz, F., Ros, E., & Acuña-Castroviejo, D. (2006) · PubMed · Cited by 67
High-Dose TGF-β1 Impairs Mesenchymal Stem Cell–Mediated Bone Regeneration via Bmp2 Inhibition
Xu, J., Liu, J., Gan, Y., Dai, K., Zhao, J., Huang, M., Huang, Y., Zhuang, Y., & Zhang, X. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3871 · Cited by 68
“progenitors, promotes the early stages of differentiation, and blocks the apoptosis of osteoblasts.((14,16,17)) On the other hand,”
BackgroundControl of Bone Matrix Properties by Osteocytes
Creecy, A., Damrath, J. G., & Wallace, J. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.578477 · Cited by 68
“At the end of their period of bone formation, late-stage osteoblasts are directed via unknown cues to either undergo apoptosis or terminal differentiation (1, 2).”
BackgroundA New Method to Investigate How Mechanical Loading of Osteocytes Controls Osteoblasts
Vazquez, M., Evans, B. A. J., Riccardi, D., Evans, S. L., Ralphs, J. R., Dillingham, C. M., & Mason, D. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00208 · Cited by 72
gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro
Shin, H., Pajevic, P. D., Sims, N. A., Kobayashi, T., Miao, D., Karaplis, A. C., Baron, R., Bringhurst, R., & Kronenberg, H. M. (2003) · Endocrinology · doi:10.1210/en.2003-0839 · Cited by 66
“decreased apoptosis of osteoblast-like cells seen in vitro (22),”
BackgroundUrayama, S., Kawakami, A., Nakashima, T., Tsuboi, M., Yamasaki, S., Hida, A., Ichinose, Y., Nakamura, H., Ejima, E., Aoyagi, T., et al. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.108754 · Cited by 66
Vermes, C., Glant, T., Hallab, N., Fritz, E. A., Roebuck, K., & Jacobs, J. (2001) · Journal of Arthroplasty · doi:10.1054/arth.2001.28719 · Cited by 68
“As mentioned earlier, TGF- 1 provides stimulatory signals for osteoblasts in general [25], and this growth factor is an effective up-regulator of procollagen 1[I] gene expression and osteoblast proliferation [21].”
BackgroundOsteoblasts in Bone Physiology – Mini Review
Rosenberg, N., Rosenberg, O., & Soudry, M. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10080 · Cited by 64
Arsenic induces cell apoptosis in cultured osteoblasts through endoplasmic reticulum stress
Tang, C., Chiu, Y., Huang, C.-F., Chen, Y., & Chen, P. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.011 · Cited by 65
Sowa, H., Kaji, H., Iu, M.-F., Tsukamoto, T., Sugimoto, T., & Chihara, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302566200 · Cited by 65
Granito, R. N., Rennó, A. C. M., Ravagnani, C., Bossini, P. S., Mochiuti, D., Jorgetti, V., Driusso, P., Peitl, O., Zanotto, E. D., Parizotto, N. A., et al. (2011) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31795 · Cited by 64
“In effect, the rate of bone formation is largely determined by the rate of osteoprogenitors replication; the number of active osteoblasts, which was indeed significantly higher in Biosilicate R group; and the life-span of these cells.(23,24) In fact, recent research shows that the critical stage of reaction for bone r…”
BackgroundBone remodeling: A tissue-level process emerging from cell-level molecular algorithms
Arias, C. F., Herrero, M. A., López, L. F. E., Oleaga, G. E., & López, J. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204171 · Cited by 72
Use of beta‐2 agonists and risk of hip/femur fracture: a population‐based case‐control study
de Vries, F., Pouwels, S., Bracke, M., Leufkens, H. G. M., Cooper, C. C., Lammers, J. J., & van Staa, T. P. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1318 · Cited by 63
Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles
Pioletti, D. P., Leoni, L. M., Genini, D., Takei, H., Du, P., & Corbeil, J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10218 · Cited by 64
“Apoptosis quantification is important as it is the normal fate for the majority of osteoblasts.(13) Moreover, an in vitro study showed that Ti particles can induce apoptosis in osteoblasts.”
BackgroundVuong, J., & Hellmich, C. (2011) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2011.07.028 · Cited by 63
3D printed tissue engineered model for bone invasion of oral cancer
Almela, T., Al‐Sahaf, S., Brook, I. M., Khoshroo, K., Rasoulianboroujeni, M., Fahimipour, F., Tahriri, M., Dashtimoghadam, E., BOLT, R. J., Tayebi, L., et al. (2018) · Tissue and Cell · doi:10.1016/j.tice.2018.03.009 · Cited by 63
Role of Medicinal Plants and Natural Products on Osteoporotic Fracture Healing
Jalil, M. A. A., Shuid, A. N., & Muhammad, N. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/714512 · Cited by 62
Bone Tissue Formation from Human Embryonic Stem Cells In Vivo
Tremoleda, J., Forsyth, N. R., Khan, N. S., Wojtacha, D., Christodoulou, I., Tye, B. J., Racey, S. N., Collishaw, S., Sottile, V., Thomson, A. J., et al. (2008) · Cloning and Stem Cells · doi:10.1089/clo.2007.0r36 · Cited by 62
“In vivo , osteoblastic cells are known to be depleted by apoptosis at the end of their bone-forming cycle and to be subsequently replaced by osteoblast precursors from the stromal stem cell population (Jilka et al., 1998; Parfit, 1994).”
Bone and the Innate Immune System
Charles, J. F., & Nakamura, M. C. (2014) · Current Osteoporosis Reports · doi:10.1007/s11914-014-0195-2 · Cited by 58
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
Hoermann, G., Greiner, G., & Valent, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/869242 · Cited by 61
Ghali, O., Chauveau, C., Hardouin, P., Broux, O., & Devedjian, J.-C. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.52 · Cited by 61
Cell Proliferation and Apoptosis During Fracture Healing
Li, G., White, G., Connolly, C., & Marsh, D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.791 · Cited by 61
Takagi, M., Santavirta, S. S., Ida, H., Ishii, M., Takei, I., Niissalo, S., Ogino, T., & Konttinen, Y. T. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.79 · Cited by 61
“It may suggest bipolar potential of monocytes/macrophages; they not only produce osteoclastic cytokines such as interleukin-1 (IL-1), IL-6, tumor necrosis factora (TNF-a), and macrophage colony–stimulating factor (M-CSF) contributing to osteoclastogenesis and activation of osteoclast, but also stimulate osteoblast and…”
BackgroundLi, M., Wang, W., Wang, P., Yang, K., Sun, H., & Wang, X. (2010) · Molecules · doi:10.3390/molecules15107403 · Cited by 60
“It is demonstrated that apoptosis (programmed cell death) represents the most common fate of osteoblasts during physiologic bone remodeling [24,25].”
BackgroundIn Toto Imaging of Dynamic Osteoblast Behaviors in Regenerating Skeletal Bone
Cox, B. D., Simone, A. D., Tornini, V. A., Singh, S. P., Talia, S. D., & Poss, K. D. (2018) · Current Biology · doi:10.1016/j.cub.2018.10.052 · Cited by 62
Nagase, Y., Iwasawa, M., Akiyama, T., Kadono, Y., Nakamura, M., Oshima, Y., Yasui, T., Matsumoto, T., Hirose, J., Nakamura, H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016915 · Cited by 59
Dexamethasone induces caspase activation in murine osteoblastic MC3T3-E1 cells
Chua, C. C., Chua, B. H. L., Chen, Z., Landy, C., & Hamdy, R. C. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00100-9 · Cited by 59
“[10] demonstrated that apoptosis is the main fate for most osteoblasts.”
BackgroundMundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 59
Cerri, P. S., Boabaid, F., & Katchburian, E. (2003) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2003.02006.x · Cited by 57
Transcriptional networks controlling stromal cell differentiation
Rauch, A., & Mandrup, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00357-7 · Cited by 57
Dominici, M., Marino, R., Rasini, V., Spano, C., Paolucci, P., Conte, P., Hofmann, T. J., & Horwitz, E. M. (2008) · Blood · doi:10.1182/blood-2007-10-115725 · Cited by 59
Compressive Force Induces Osteoblast Apoptosis via Caspase-8
Goga, Y., Chiba, M., Shimizu, Y., & Mitani, H. (2006) · Journal of Dental Research · doi:10.1177/154405910608500307 · Cited by 58
“…and differentiation (Jacobson et al., 1997), also serves to protect an organism from extracellular stress induced by the removal of growth factors (Jilka et al., 1998), exposure to radiation (Haimovitz-Friedman et al., 1994), or the administration of anti-cancer drugs (Boesen-de Cock et al.,…”
BackgroundInfluentialEditorial: Cell Number Versus Cell Vigor--What Really Matters to a Regenerating Skeleton?
Manolagas, S. C. (1999) · Endocrinology · doi:10.1210/endo.140.10.7129 · Cited by 59
Self-citationVermes, C., Jacobs, J. J., Zhang, J., Firneisz, G., Roebuck, K. A., & Glant, T. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200546200 · Cited by 55
Mohd Effendy, N., Mohamed, N., Muhammad, N., Naina Mohamad, I., & Shuid, A. N. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/125761 · Cited by 55
“They mediate osteoclastogenesis by stimulating osteoclast differentiation and inhibiting apoptosis of osteoclast progenitors [53, 54].”
BackgroundRole of Autophagy in Tumor Necrosis Factor-α-Induced Apoptosis of Osteoblast Cells
Zheng, L., Wang, W., Ni, J., Mao, X., Song, D., Liu, T., Wei, J., & Zhou, H. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000426 · Cited by 55
McMillan, A., Nguyen, M. K., Gonzalez‐Fernandez, T., Ge, P., Yu, X., Murphy, W. L., Kelly, D. J., & Alsberg, E. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.006 · Cited by 55
“The decrease in average DNA by 4 weeks in many of the conditions is potentially a result of culture with osteogenic and hypertrophic factors inducing chondrocyte hypertrophy and apoptosis [79].”
Huynh, C. T., Liu, F., Cheng, Y., Coughlin, K. A., & Alsberg, E. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b07167 · Cited by 55
de Hooge, A. D., van de Loo, F. V. D., Bennink, M., de Jong, D. S., Arntz, O., Lubberts, E., Richards, C. D., & van den Berg, W. (2002) · American Journal of Pathology · doi:10.1016/s0002-9440(10)61120-0 · Cited by 62
Bone markers in multiple myeloma
Heider, U., Fleissner, C., Zavrski, I., Kaiser, M., Hecht, M., Jakob, C., & Sezer, O. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.034 · Cited by 55
Alexander, E., Bento, J. L., Hughes, F. M., Marriott, I., Hudson, M., & Bost, K. L. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1581-1586.2001 · Cited by 55
The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism
Iwamoto, I., Fujino, T., & Douchi, T. (2004) · Gynecological Endocrinology · doi:10.1080/09513590412331284389 · Cited by 54
Metadata
- Authors
- Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C.
- Affiliations
- University of Arkansas Medical Center (US)
- Corresponding author
- Jilka, Robert L.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-05-01
- Volume
- 13
- Issue
- 5
- Pages
- 793-802
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2075292460
- Cited by
- 578
- References
- 40
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 19 · 2023: 14 · 2022: 10 · 2021: 17 · 2020: 12 · 2019: 16 · 2018: 21 · 2017: 17 · 2016: 17 · 2015: 17 · 2014: 20 · 2013: 21 · 2012: 24
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG013918)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- osteoblast apoptosis, programmed cell death, growth factors, cytokines, TGF-beta, interleukin-6, TNF-α, Fas, Bax/Bcl-2 ratio, oncostatin M, bone remodeling, osteocytes, bone lining cells, MC3T3-E1 cells, MG-63 cells, bone microenvironment
- MeSH terms
- Animals, Bone and Bones, Cell Line, Growth Substances, Humans, Osteoblasts, Recombinant Proteins, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Transforming Growth Factor beta, Bone Remodeling, Apoptosis, Receptors, Interleukin-6, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review